27 - 28 November, 2018 | London, UK

Jamie Kemler


VP, Intellectual Property Business Strategy
Stryker


9:15 IP Monetisation in the Life Sciences: A Broader Perspective

An assessment of the various options available to your organisation with regards to monetisation,
How can you further monetize your IP assets through licensing, cross-licensing etc?
Focusing on licensing patents to start-ups, right of reference to clinical data, software and tools, and technology licenses outside of your core markets
Taking a broad view of un-used and non-core IP including trademarks and discontinued products opens up additional opportunities to monetize a life-science IP portfolio.


Check out the incredible speaker line-up to see who will be joining Jamie.

Download The Latest Agenda